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Abstract
Background: HIV-exposed uninfected (HIVe) children are a rapidly growing population that may be at an
increased risk of illness compared to HIV-unexposed children (HIVn). The aim of this study was to investigate the
morbidity and mortality of HIVe compared to both HIVn and HIV-infected (HIVi) children after a general surgical
procedure.
Methods: A prospective study of children less than 60 months of age undergoing general surgery at a paediatric
referral hospital from July 2004 to July 2008 inclusive. Children underwent age-definitive HIV testing and were
followed up post operatively for the development of complications, length of stay and mortality.
Results: Three hundred and eighty children were enrolled; 4 died and 11 were lost to follow up prior to HIV
testing, thus 365 children were included. Of these, 38(10.4%) were HIVe, 245(67.1%) were HIVn and 82(22.5%) were
HIVi children.
The overall mortality was low, with 2(5.2%) deaths in the HIVe group, 0 in the HIVn group and 6(7.3%) in the HIVi
group (p = 0.0003). HIVe had a longer stay than HIVn children (3 (2-7) vs. 2 (1-4) days p = 0.02). There was no
significant difference in length of stay between the HIVe and HIVi groups. HIVe children had a higher rate of
complications compared to HIVn children, (9 (23.7%) vs. 14(5.7%) (RR 3.8(2.1-7) p < 0.0001) but a similar rate of
complications compared to HIVi children 34 (41.5%) (RR = 0.6 (0.3-1.1) p = 0.06).
Conclusion: HIVe children have a higher risk of developing complications and mortality after surgery compared to
HIVn children. However, the risk of complications is lower than that of HIVi children.
Background
HIV-exposed uninfected (HIVe) children are a rapidly
growing population. Programs for the prevention of
mother to child transmission (PMTCT) have reduced
the transmission rate of perinatal HIV infection to
approximately 2% to 5% [1-3]. Such programs have
therefore effectively reduced the number of HIV
infected (HIVi)children but identified an increasing
population of HIVe children [4].
HIVe children have been overlooked as a group of
children who may be at an increased risk of illness com-
pared to HIV-unexposed (HIVn) children. Recently,
increased morbidity and mortality in HIVe children
compared to HIVn children has been reported [4-10].
Many factors may account for this including innate defi-
ciencies in immunity [11-13], feeding practices [14],
poor protection from maternal antibodies or environ-
mental exposures [6].
As PMTCT programs expand, an increasing number
of HIVe children can be expected to require a routine
or emergency surgical procedure [15,16]. Currently no
data exist on the risk of morbidity and mortality post-
surgery in such children. The aim of this study was to
investigate the mortality and post-operative complica-
t i o n si nH I V ec h i l d r e nc o m p a r e dt ob o t hH I V na n d
HIVi children after a general surgical procedure.
Methods
A prospective cohort study was performed, from July
2004 to July 2008 at a single tertiary general paediatric
surgical centre in Cape Town, Western Cape, South
Africa. The general paediatric surgical service acts as a
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2400 operations performed annually. The study was
approved by the ethics committee of the Faculty of
Health sciences, University of Cape Town.
The study site is a high HIV prevalence area, with an
estimated HIV prevalence amongst pregnant women of
approximately 16% [17]. There is a well-developed
PMTCT program with HIV transmission rates of
approximately 2-4%. The Western Cape has approxi-
mately 70000 births per annum [1], of which approxi-
mately 11000 babies per year are expected to be HIVe.
Inclusion criteria were children less than 60 months of
age, undergoing a general surgical procedure. The
recruitment was conducted in two phases. 1) Phase 1
(pilot data), enrolled only HIV-exposed children, from
July 2004 to December 2006. This was done to gather
pilot data, to inform the larger phase 2 study. 2) Phase 2
enrolled all children irrespective of HIV exposure from
January 2007 until July 2008 inclusive. Analysis was con-
ducted on both phase 1 and phase 2 data.
Age definitive HIV testing with pre and post-test
counselling was done in children whose HIV status was
unknown. HIV infection was defined as 2 positive HIV
ELISA (Determine
®Abbott, Abbott Park, Ill. USA) tests
in children > 18 months; a positive ELISA test, and if
positive a confirmatory PCR test in children less than 18
months. HIV exposure was defined as a positive ELISA
but negative PCR in children < 18 months or in children
> 18 months knowledge of an infected mother but a
negative ELISA in the child.
Informed consent from a parent or legal guardian was
obtained. Details of the child’s demographics, clinical
examination, medication, haematological tests, HIV sta-
tus and treatment, surgery and complications were
recorded until discharge, death or in the case of pro-
longed admissions 60 days following their last surgical
procedure or surgical complication.
Children formed 3 groups- 1. HIV-exposed (HIVe) but
uninfected 2.HIV unexposed (HIVn), 3. HIV infected
(HIVi). HIVe children were compared to the HIVn and
the HIVi groups
A procedure entailed a general surgical operation
under general anaesthetic. Surgical procedures were
defined as emergency (which in the opinion of the treat-
ing clinician unless performed in 24 hours of hours of
admission would result in either morbidity or mortality
of the child) or elective. Procedures were also defined as
major (which entailed entry into a body cavity (abdomen
or thorax), oncological resection, and a prolonged pro-
cedure longer than 90 min or vascular reconstruction)
or minor. A contaminated case was defined as pus,
infection, or gross contamination present at the site of
surgery when performing the procedure. Prophylactic
antibiotics were used in major cases or contaminated
cases according to local microbiological guidelines. This
included a cephalosporin and metronidazole or alterna-
tively, penicillin an aminoglycoside and metronidazole,
depending on the procedure.
The primary outcome was the occurrence of a compli-
cation, defined as an adverse event occurring in the
intra, or post-operative period which is not expected to
occur either during or following the normal course of
the procedure. Secondary outcomes were length of stay
(calculated in days from the day of admission until the
day of discharge or death) and mortality.
Statistical analysis
Descriptive data is presented as means +/- standard
deviation, medians with an interquartile range (IQR) or
proportions with a 95% confidence interval. Normality
of data was tested using the Shapiro-Wilks test. Hypoth-
esis testing, using either the chi squared or fisher exact
test for dichotomous or ordinal variables was done. The
student t-test was used for the comparison of means
and the Wilcoxon rank-sum test for comparing medians
of continuous variables. Nutrition assessed using weight
for height Z scores as a continuous variable and a
dichotomous variable with a weight for age Z-Score of
less than -2 being malnourished. Relative risks were cal-
culated for complications or mortality. Following the
initial comparisons, age adjusted control groups were
formed in the HIVn and HIVi groups due to the signifi-
cantly younger age of the HIVe children. This was done
by selecting appropriate matched controls within one
m o n t ho fa g ef o re a c hH I V ec a s e .D u et ot h es a m p l e
size, 3 age matched controls could be selected from the
HIVn group, and a single age matched control from the
HIVi group. Furthermore age as a confounding variable
was tested on multivariate analysis in three different
models, the entire cohort, HIVe and HIVn children and
HIVe and HIVi children. The regression models were
constructed for complications. This was done by includ-
ing factors significant on univariate analysis or alterna-
tively of strong clinical importance as a backward step
regression until the best fit was obtained. Data was ana-
lysed using Stata (Version10.0, College Station, Tx
USA). Significance was set at p < 0.05 and results were
expressed as proportions and relative risk with 95% con-
fidence intervals.
Results
T h r e eh u n d r e da n de i g h t yc h i l d r e nw e r ee n r o l l e d( 9 4
during, phase 1); 4 died and 11 were lost to follow up
prior to PCR testing, thus 365 children were included.
Of these, 38(10.4%) were HIVe, 245(67.1%) were HIVn
and 82(22.5%) were HIVi children.
The median age of children was 11 (IQR 4.4-26.6)
months. HIVe children were younger, 4.5 (IQR 0.8-11.2)
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Page 2 of 6months than the HIVi (11.5 months (IQR 6-24) p <
0.0001) or HIVn (12.7 months (IQR 4.4-29.4) p = <
0.0001) children. HIVe children had a higher number of
major procedures, contamination at the surgical site and
worse nutrition compared to HIVn children (table 1).
Following age matching of HIVe and HIVn children, an
increased surgical site contamination and worse nutri-
tion persisted in HIVe children (table 2). HIVe and
HIVi children were well matched for the level of proce-
dure, surgical site contamination, urgency, nutrition and
number of urgent procedures in both the age matched
and unmatched groups (table 3, 4)
The overall mortality (8 deaths, 2.2%) was low, with 2
(5.2%) deaths in the HIVe group, none in the HIVn
group and 6(7.3%) in the HIVi group. The mortality rate
w a ss i g n i f i c a n t l yh i g h e ri nH I V ec o m p a r e dt oH I V n
children (p = 0.0003). This difference persisted when
matching for age p = 0.01 (table 2). No significant dif-
ference in mortality was demonstrated between HIVe
and HIVi children (table 3, 4).
HIVe had a longer duration of hospitalisation than
HIVn children (3 (2-7) vs. 2 (1-4) days p = 0.02), but
this difference did not persist with age matching of the
groups ((3 (2-7) vs. 2 (1-5) days p = 0.2). There was no
significant difference in length of stay between the HIVe
and HIVi groups.
Overall 57 (15.6%) children developed a complication.
T h eH I V ec h i l d r e nh a dah i g h e rr a t eo fc o m p l i c a t i o n s ,
compared to HIVn children [9 (23.7%) vs. 14(5.7%) (RR
4.18(1.9-8.9) p < 0.0001)] (table 1), but a similar rate
compared to HIVi children [9(23.7%) vs. 34 (41.5%) (RR
= 0.6 (0.3-1.1) p = 0.06)] (table 3). Using aged matched
controls there was still a significant difference in the
rate of complications between HIVe and HIVn children
[9 (23.7%) vs. 10 (8.7%) (RR 2.3 (1.3-4.1) p = 0.008)]
(table 2). After age matching, HIVe children had a lower
risk of complications than HIVi children [(9(23.7%) vs.
24 (63.2%)(RR 0.4 (0.2-0.7) p = 0.0005)] (table 4)
A total of 71 complications occurred in 57 children
(table 5). The commonest complications were surgical
site complications in 34/71 (48%). Of these 13/34(38%)
were wound infection, 7/34(20.5%) were wound break-
down (without clinical or microbiological infection), 7/
34(20.5%) involved breakdown of an enteric stoma, 4/34
(11%) were early recurrence of the surgically treated
condition and 3/34(9%) were anastomotic obstruction or
Table 1 Comparison of HIV exposed uninfected and HIV unexposed children
HIVe(n = 38) HIVn(n = 245) Relative Risk Significance
Age(months) 4.5 (0.8-11.2) 12.7(4.4-29.4) p < 0.00001*
Nutrition
￿ Z-score weight for age -1.74 (-3.4- -0.5) -0.63(-1.7-0.18) P = 0.0002*
￿ Malnutrition (Z-score<-2) 18 (47.4%) 43 (17.5%) RR = 2.7(1.8-4.2) p < 0.00001*
Major cases 17 (44.7%) 64 (26.1%) RR = 1.7(1.2-2.6) P = 0.01*
Contaminated cases 15 (39.4%) 49 (20%) RR = 2 (1.3-3.1) P = 0.008*
Emergency cases 12 (31.5%) 95 (38.8%) P = 0.8
No. of patients with a Complication 9 (23.7%) 14 (5.7%) RR = 4.2 (1.9-8.9) p < 0-.0001*
Mortality 2 (5.2%) 0(0%) P = 0.0003*
Length of stay (days) 3-(2-7) 2(1-4) P = 0.02*
Values expressed as medians (interquartile range) for continuous and number (percentage) for dichotomous variables. Relative risk is expressed as the RR (95%
confidence interval) * are significant values.
Table 2 Comparison HIV exposed uninfected children and age matched HIV unexposed children
HIVe(n = 38) Age matched HIVn(n = 114) Relative Risk Significance
Age(months) 4.5 (0.8-11.2) 4.4(1.8-11) p = 0.6
Nutrition
￿ Z-score weight for age -1.74 (-3.4- -0.5) -0.86(-1.8- 0) P = 0.01*
￿ Malnutrition (Z-score<-2) 18 (47.4%) 26 (22.8%) RR = 2 (1.3-3.3) p = 0.004*
Major cases 17 (44.7%) 34(29.8%) p = 0.09
Contaminated cases 15 (39.4%) 20(17.5%) RR = 2.1 (1.3-3.7) p = 0.01*
Emergency cases 12 (31.5%) 51(44.7%) p = 0.2
No. of patients with a Complication 9 (23.7%) 10(8.7%) RR = 2.3 (1.3-4.1) p = 0.008*
Mortality 2 (5.2%) 0(0) p = 0.01*
Length of stay (days) 3-(2-7) 2(1-5) P = 0.2
Values expressed as medians (interquartile range) for continuous and number (percentage) for dichotomous variables. Relative risk is expressed as the RR (95%
confidence interval) * are significant values.
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Page 3 of 6stenosis. The second commonest complication was post-
operative systemic infection, comprising pneumonia in
10/31(32%), sepsis with bacteraemia in 13/31(42%), cen-
tral line sepsis 5/31(16%) and one case each of cholangi-
tis, urinary infection and intra-abdominal sepsis 3/31
(10%). Other complications occurring in 6/71(8%)
included postoperative airway obstruction due to vocal
cord palsy, dehydration and hypoglycaemia. Of the com-
plications recorded, HIVe children had a higher propor-
tion of systemic post-operative infections than both
HIVn children [12/16(75%) vs. 8/18(44%) p = 0.05 RR
1.7 (1.1-3)] and HIVi children [12/16(75%) vs. 11/37
(30%) p = 0.002 RR = 2.5(1.4-4.5)]
Logistic regression comparing HIVe and HIVn chil-
dren and HIVe and HIVi children included significant
variables on univariate analysis, and other clinically
important variables such as nutrition, urgency of surgery
and surgical site contamination. Following backward
step regression for HIVe and HIVn children it was
demonstrated that HIV exposure and undergoing a
major procedure were the most predictive of developing
a complication (table 6). Models for HIVe and HIVi
children demonstrated that HIV status, age under 12
months and undergoing a major procedure were the
most predictive of developing a complication (table 7).
Discussion
This study has shown that HIVe children undergoing
surgery have an intermediate risk of complications post-
surgery; higher than that of HIVn children, but lower
than HIV infected HIVi children. In addition, in hospital
mortality post-surgery was higher in HIVe children
compared to that in HIVn children.
The increased morbidity and mortality related to HIV
exposure may be due to many factors. HIVe children
may have poorer growth and nutrition, increased risk of
infection, impaired passive immunity from maternal
antibodies, or greater exposure to potential pathogens in
a household with a HIV infected adult.
HIVe children had worse nutrition compared to those
who were HIVn. Reasons for poorer nutrition may
include parental illness and poverty [18,19], infant feed-
ing practices [14,18], lack of breast feeding, and an
increase disease burden in exposed children [6,13,14,19].
Although breast feeding rates were not recorded, it is
likely that there would have been a low breast feeding
Table 3 Comparison of HIV exposed uninfected and HIV infected children
HIVe(n = 38) HIVi(n = 82) Significance
Age(months) 4.5 (0.8-11.2) 11.5(6-24) p < 0.0001*
Nutrition
￿ Z-score weight for age -1.74 (-3.4- -0.5) -2.0(-3.4- -0.97) P = 0.7
￿ Malnutrition (Z-score<-2) 18 (47.4%) 41 (50.0%) P = 0.8
Major cases 17 (44.7%) 28 (34.2%) P = 0.1
Contaminated cases 15 (39.4%) 40 (48.7%) P = 0.2
Emergency cases 12 (31.5%) 37 (45.1%) P = 0.8
No. of patients with a Complication 9 (23.7%) 34 (41.5%) P = 0.06
Mortality 2 (5.2%) 6 (7.3%) P = 0.8
Length of stay (days) 3-(2-7) 4(2-14) P = 0.5
Values expressed as medians (interquartile range) for continuous and number (percentage) for dichotomous variables. Relative risk is expressed as the RR (95%
confidence interval) * are significant values.
Table 4 Comparison HIV exposed uninfected and age matched HIV infected children
HIVe(n = 38) Age matched HIVi(n = 38) Relative Risk Significance
Age(months) 4.5 (0.8-11.2) 6(4.4-10) p = 0.4
Nutrition
￿ Z-score weight for age -1.74 (-3.4- -0.5) -1.9(+/-1.7) P = 0.9
￿ Malnutrition (Z-score<-2) 18 (47.4%) 19 (50%) P = 0.8
Major cases 17 (44.7%) 16 (42.1%) P = 0.8
Contaminated cases 15 (39.4%) 20(52.6%) P = 0.2
Emergency cases 12 (31.5%) 14 (36.8%) P = 0.6
No. of patients with a Complication 9 (23.7%) 24 (63.2%) RR = 0.40
(0.22-0.73)
P = 0.0005*
Mortality 2 (5.2%) 5 (13.1%) P = 0.4
Length of stay (days) 3-(2-7) 4(2-22) P = 0.2
Values expressed as medians (interquartile range) for continuous and number (percentage) for dichotomous variables. Relative risk is expressed as the RR (95%
confidence interval) * are significant values.
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mula feeding of children born to HIV-infected mothers
in the Western Cape Province at the time of the study.
Several cohort studies have reported HIVe children to
have worse nutrition compared to HIVn children [19].
HIVe children have been reported to have an
increased risk of infection compared to HIVn children
[4,6,10,19-23]. Infections in HIVe also tend to be more
severe than in HIVn children [6,10,19,24,25]. Many of
these infections are opportunistic infections occurring in
an immune-compromised host [4,10,19,24]. There
appears that in addition to environmental and feeding
practices HIVe children have an impaired innate immu-
nity [5,19]. This may increase susceptibility to infection
and increase the risk for developing post-operative
complications. This was consistent with our findings of
ah i g hr a t eo fi n f e c t i o n si nH I V ec h i l d r e np o s t
operatively.
Major procedures are a clearly identified risk factor
associated with an increased risk for the development of
complications [26] and risk stratification to account for
complications is well described [27,28]. Increased com-
plexity of the procedure (thus increasing the risk of
technical problems), immune dysregulation related to
the stress response to surgery or impaired respiratory
function in the post-operative period may all contribute
to this [29].
There are several limitations to this study. The rela-
tively lower age of the HIVe compared with HIVi and
HIVn patients may have been a confounding variable as
the HIVe children may not have had a fully developed
immune system. We have attempted to account for this
in multivariate analysis and secondly by age matching to
HIVi and HIVn children. In both instances when age
was accounted for, HIV status had an important effect
on post-operative outcomes with HIVe children having
a risk in between that of HIVn and HIVi children. This
study has a small number of HIVe children which may
have influenced the results and larger studies are needed
with stratification of the HIVe group based on age of
the child, feeding practice and the stage of maternal
HIV disease. Lastly as this was an observational cohort
s t u d yH I Vr e s u l t sw e r en o tb linded to either treating
physicians or observers and this may have resulted in
some reporting bias.
Conclusion
This is the first study to report that HIVe children
undergoing surgery have a higher risk of developing
complications and mortality compared to HIVn chil-
dren, but a lower risk than that of HIVi children. This
should be considered when assessing the risk benefit
ratio and age of any surgical procedure.
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HIV Status
Total Complications (71) HIVi (37) HIVn
(18)
HIVe
(16)
Systemic Post-operative infection 31/
71(44%)
11/37
(30%)
8/18
(44%)
12/16
(75%)
Pneumonia 5/11
(45.5%)
2/8(25%) 3/12
(25%)
Bacteraemia 5/11
(45.5%)
2/8(25%) 6/12
(50%)
Central Line sepsis 1/11(9%) 2/8(25%) 2/12
(16.7%)
Urinary tract 0 1/8
(12.5%)
0
Cholangitis 0 1/8
(12.5%)
0
Intra-abdominal 0 0 1/12
(8.3%)
Surgical site complication 34/71(48%) 24/37
(65%)
6/18
(33%)
4/16
(25%)
Wound Infection 8/24(33%) 3/6(50%) 2/4(50%)
Wound break down 7/24(29%) 0 0
Stoma complication 5/24(21%) 1/6(17%) 1/4(25%)
Recurrence 4/24(17%) 0 0
Anastomotic obstruction/stenosis 0 2/6(33%) 1/4(25%)
Miscellaneous 6/71 (8%) 2/37(5%) 4/18
(22%)
0
Table 6 Logistic regression for complications with HIV
exposed uninfected children and HIV unexposed children
Variable Odds
Ratio
Significance 95% confidence
interval
HIV exposure 4.9 P = 0.006 1.6-15.4
Age 0.9 P = 0.09 0.9-1.2
Major
procedure
9.2 p < 0.0001 3.2-25.0
Table 7 Logistic regression for complications with HIV
exposed uninfected children and HIV infected children
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Ratio
Significance 95% confidence
interval
HIV exposure 0.5 p = 0.01 0.3-0.8
Age under 12
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5.2 p = 0.001 1.9-14.4
Major procedure 5.5 p < 0.0001 2.1-14.0
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